Advantix Medium Dog Pest Control Solution 10 to 25kg 4 pipettes
Advantix 4 pipettes for medium sized dogs 10-25kg.
DescriptionAdvantix Parasite Solution for Dogs is a preventative and treatment for flea infestations.
WIDE SPECTRUM OF ACTION: Advantix® protects against 6 parasites, the broadest spectrum of any external dog pest control product.
CONTACT EFFECTIVENESS: Advantix® works on parasites before they bite your pet, avoiding pain, discomfort and stress.
REPELLENT ACTION: Advantix® acts as an invisible protective barrier that repels ticks that are approaching your dog to bite.
GOOD TOLERANCE: Advantix® can be used on puppies as young as 7 weeks of age and on pregnant or lactating females.
PRACTICAL: Advantix® pipettes are easy to apply.
Fleas on the dog are killed within 24 hours of treatment. A single treatment prevents re-infestation by fleas for 4 weeks. The drug can be integrated into a treatment programme for Flea Allergy Dermatitis (FAD).
The product has an acaricidal and repellent effect on ticks, persisting for 4 weeks (Rhipicephalus sanguineus, Ixodes ricinus) and 3 weeks (Dermacentor reticulatus).
Through its repellent and acaricidal action on the tick vector Rhipicephalus sanguineus, the product reduces the likelihood of transmission of the pathogen Ehrlichia canis, thereby reducing the risk of canine ehrlichiosis. Studies have shown that this protection starts as early as the 3rd day after application of the product and lasts for 4 weeks.
Ticks already on the dog at the time of treatment may not be killed for 2 days after treatment and may remain attached and visible. It is therefore recommended that any ticks present at the time of treatment are removed to avoid attachment and blood feeding.
A single treatment provides repellent activity (anti-gorging) against sandflies for a fortnight (Phlebotomus papatasi) to three weeks (Phlebotomus perniciosus), against mosquitoes for a fortnight (Aedes aegypti) to four weeks (Culex pipiens) and against stable flies (Stomoxys calcitrans) for four weeks.
IndicationsFor dogs weighing 10-25kg.
Prevention and treatment of flea infestations (Ctenocephalides canis, Ctenocephalides felis).
Treatment of chewing lice infestations (Trichodectes canis).
Reduction of the risk of infection with Leishmania infantum transmitted by sandflies (Phlebotomus perniciosus) for up to 3 weeks. The effect is indirect due to the activity of the product on the vector.
Directions for useAdvantix® is a veterinary medicine. Read the package insert and directions carefully before use. Ask your veterinarian/pharmacist/animal health professional for advice. If symptoms persist, consult your veterinarian.
In the absence of available data, do not treat puppies under 7 weeks of age. Do not use in dogs weighing less than 1.5 kg. Do not use in case of known hypersensitivity to the active ingredients or to any of the excipients. Do not use in cats.
Avoid contact of the product with the skin, eyes and mouth. Do not eat, drink or smoke during application. Wash hands thoroughly after application. In case of accidental skin contact, wash immediately with soap and water. People with known skin sensitivities may be particularly sensitive to this product. The predominant, although extremely rare, symptoms that may be observed are transient sensory irritation of the skin such as tingling, burning or numbness. In case of accidental contact with the eyes, rinse the eyes thoroughly with water. If skin or eye irritation persists, consult a physician and show the product label. Do not ingest. In case of accidental ingestion, seek medical advice immediately and show the instructions and packaging. Do not allow children to play with treated animals until the application site is dry. This can be ensured by treating the animals in the evening, for example. In this case, do not let newly treated dogs sleep with their owners, especially if they are children. To prevent children from coming into contact with the pipettes, keep the pipettes in their original packaging until use, and dispose of used pipettes immediately. VGPR 11/2020.